Industry reports
Editor highlights

Search inside this page

All regions

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics in Germany, May 2013 (p5)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

121-170 of about 1 100 reports
Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : World, Australia, Brazil, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, China, Oceania
Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : Brazil, World, Australia, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, China, South America, Oceania
NeisVac-C (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

NeisVac-C (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

NeisVac-C (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : World, Australia, Brazil, Spain, Italy, France, Germany, Japan, United Kingdom, Europe, United States, China, Oceania
Bexsero (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Bexsero (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Bexsero (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, Australia, Europe, United States, United Kingdom, China
PharmaPoint: Meningococcal Vaccines - Germany Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - Germany Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • September 2013
  • by Global Data

PharmaPoint: Meningococcal Vaccines - Germany Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - Germany Drug Forecast ...

  • Industries : Drug and Medication
  • Countries : Germany
MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts

MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts

  • $ 4 450
  • Industry report
  • September 2013
  • by Global Data

MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts Summary GlobalData has released its medical devices report, “MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts”. ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, World, Europe
EpiCast Report: Acute Ischemic Stroke - Epidemiology Forecast to 2022

EpiCast Report: Acute Ischemic Stroke - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • September 2013
  • by Global Data

EpiCast Report: Acute Ischemic Stroke - Epidemiology Forecast to 2022 Summary Stroke occurs when the blood supply to the brain is blocked or interrupted, either by blood clots or ruptured blood vessels, ...

  • Industries : Pathology
  • Countries : France, United States, Spain, Italy, Germany, United Kingdom, World, Europe
Alopecia - Pipeline Review, H2 2013

Alopecia - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • September 2013
  • by Global Markets Direct

Alopecia - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Alopecia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Therapy
  • Countries : Germany, World
Germany Business Projection Industry Update Quarter 4 2011

Germany Business Projection Industry Update Quarter 4 2011

  • $ 1 208
  • Industry report
  • September 2013
  • by Business Monitor International

Core Views Although the German economy continues to fire on all cylinders, underpinning our constructive (above-consensus) outlook for Europe’s largest economy, we see leading expectations indicators ...

  • Industries : Drug and Medication
  • Countries : Germany
EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • August 2013
  • by Global Data

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022 Summary Overweight and obesity are characterized by abnormal or excessive fat accumulation in the body, which can increase the likelihood ...

  • Industries : Pathology
  • Countries : Brazil, Canada, Italy, France, Japan, World, United States, United Kingdom, Spain, Germany
EpiCast Report: Acne - Epidemiology Forecast to 2022

EpiCast Report: Acne - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • August 2013
  • by Global Data

EpiCast Report: Acne - Epidemiology Forecast to 2022 Summary Acne vulgaris (acne) is an inflammatory skin disease that affects nearly all adolescents and adults at some point in their lives. The clinical ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, World, United States, Europe, United Kingdom
EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2022

EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • August 2013
  • by Global Data

EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2022 Summary Chronic kidney disease (CKD), or chronic renal disease, is an asymptomatic, long-term condition that damages the kidneys ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, United States, World, Europe, United Kingdom
Germany Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Germany Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2013
  • by Business Monitor International

BMI View: Despite the threat of austerity measures, the government’s focus on cost-containment within the pharmaceuticals and healthcare segment and the impact of generic competition as a result of the ...

  • Industries : Drug and Medication
  • Countries : Germany
Generics Market Overview in Germany

Generics Market Overview in Germany

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

  • Industries : Generic Drug
  • Countries : Germany
OTC Pharmaceuticals Market Overview in Germany

OTC Pharmaceuticals Market Overview in Germany

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

  • Industries : Over-the-counter Drug
  • Countries : Germany
EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022

EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • August 2013
  • by Global Data

EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022 Summary Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ ...

  • Industries : Pathology
  • Countries : United States, World, Spain, Italy, France, Germany, Japan, Europe, United Kingdom
Ear Care Market Analysis in Germany

Ear Care Market Analysis in Germany

  • $ 898
  • Industry report
  • August 2013
  • by Euromonitor International

This lack of confidence to treat ear problems themselves continued to negatively affect the category also in 2010. Euromonitor International's report offers a comprehensive guide to the size and shape ...

  • Industries : Drug and Medication
  • Countries : Germany
Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Germany

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Germany

  • $ 898
  • Industry report
  • August 2013
  • by Euromonitor International

The main reason for the decline in value sales is the fact that the proportion of Germans treating their cough and colds with self-medication declined in comparison to the number of Germans who used prescription ...

  • Industries : Drug and Medication
  • Countries : Germany
Digestive Remedies Market Analysis in Germany

Digestive Remedies Market Analysis in Germany

  • $ 898
  • Industry report
  • August 2013
  • by Euromonitor International

Euromonitor International's report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data from 2006 to 2010 , allowing you to ...

  • Industries : Over-the-counter Drug
  • Countries : Germany
Analgesics Market Analysis in Germany

Analgesics Market Analysis in Germany

  • $ 898
  • Industry report
  • August 2013
  • by Euromonitor International

Suggestions were made to restrict the OTC packaging size of aspirin to 10g per package, ibuprofen to 8g per package and diclofenac to 500mg per package. Packages with larger quantities would be classified ...

  • Industries : Drug and Medication
  • Countries : Germany
NRT Smoking Cessation Aids Market Analysis in Germany

NRT Smoking Cessation Aids Market Analysis in Germany

  • $ 898
  • Industry report
  • August 2013
  • by Euromonitor International

Whilst the ongoing price increases and consumers’ desire to live healthier lives have also fuelled smoking cessation, demand for NRT smoking cessation aids in Germany has slowed compared to the early ...

  • Industries : Drug and Medication
  • Countries : Germany
Vitamins and Dietary Supplements Market Analysis in Germany

Vitamins and Dietary Supplements Market Analysis in Germany

  • $ 898
  • Industry report
  • August 2013
  • by Euromonitor International

It provides the latest retail sales data (2003-2008), allowing you to identify the segments driving growth. It identifies the leading firms , the leading brands and offers strategic analysis of key factors ...

  • Industries : Vitamin and Supplement
  • Countries : Germany
OTC Pharmaceuticals - World Market Group of Eight (G8) Market Overview (Market size, Segmentation and Trends Analysis)

OTC Pharmaceuticals - World Market Group of Eight (G8) Market Overview (Market size, Segmentation and Trends Analysis)

  • $ 1 495
  • Industry report
  • August 2013
  • by MarketLine

The report includes easily comparable data on industry value, volume, sector ation and industry share, plus full five year industry projections . It examines future problems, innovations and potential ...

  • Industries : Over-the-counter Drug
  • Countries : Japan, World, Russian Federation, Germany, United States, Canada, Italy, France, United Kingdom, Europe
Market Access in the EU5 - a comparative overview

Market Access in the EU5 - a comparative overview

  • $ 395
  • Industry report
  • August 2013
  • by Firstword Pharma

The sustained and challenging economic environment in the EU has impacted - and is impacting - pharmaceutical companies as never before. But success is still possible for those that understand the new ...

  • Industries : Drug and Medication
  • Countries : France, Germany, Spain, Italy, Europe, United Kingdom
Physician Views: Which diabetes company does the best marketing job? What is key for companies launching products?

Physician Views: Which diabetes company does the best marketing job? What is key for companies launching products?

  • $ 645
  • Industry report
  • August 2013
  • by Firstword Pharma

Scope The importance of marketing is increasingly coming to the fore as diabetes-focused companies battle for market superiority. AstraZeneca, Merck & Co. and Novo Nordisk have all expanded their diabetes ...

  • Industries : Pathology
  • Countries : United States, Spain, Italy, France, Germany, United Kingdom, Europe
Psychosis - Pipeline Review, H2 2013

Psychosis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Psychosis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Psychosis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Therapy
  • Countries : United States, World, Germany
MediPoint: Hernia Repair - EU Analysis and Market Forecasts

MediPoint: Hernia Repair - EU Analysis and Market Forecasts

  • $ 4 450
  • Industry report
  • July 2013
  • by Global Data

MediPoint: Hernia Repair - EU Analysis and Market Forecasts Summary Dramatic improvements in access to and quality of healthcare in the Asia Pacific region, concurrent with the introduction of next-generation ...

  • Industries : Pathology
  • Countries : Europe, World, Spain, Italy, France, Germany, United Kingdom
Premarin (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022

Premarin (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • July 2013
  • by Global Data

Premarin (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade, it ...

  • Industries : Drug and Medication
  • Countries : World, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom
PharmaPoint: Alzheimer's Disease - Germany Drug Forecast and Market Analysis to 2022

PharmaPoint: Alzheimer's Disease - Germany Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • July 2013
  • by Global Data

PharmaPoint: Alzheimer's Disease - Germany Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Alzheimer's Disease - Germany Drug Forecast ...

  • Industries : Pathology
  • Countries : Germany
Lu AE58054 (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Lu AE58054 (Alzheimer's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • July 2013
  • by Global Data

Lu AE58054 (Alzheimer's Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Lu AE58054 (Alzheimer's Disease) - Forecast and Market ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom

» Read our Company Profiles

21 Companies

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

Novartis Inc.

Switzerland

Johnson and Johnson

United States

AstraZeneca PLC

United Kingdom

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.